On the heels of the news of Roche acquiring GenMark Diagnostics, the author of today’s article shares two more leading diagnostics companies that he believes are prime COVID-19 takeover targets – and advises that “there’s definitely a chance to earn a quick 50% to 100% if you act fast.” For these two companies that could offer ways to profit from a continued “urge to merge” in the diagnostics space, CLICK HERE.
Profit From The “Urge To Merge” In The Diagnostics Space
Tags:COVID Diagnostic CompaniesDiagnostics SpaceEarn QuickGenMark DiagnosticsInvestinginvestorsMergeprofitsstock market